Fortilink-SC cervical fusion safety and performance in adults
Official title: Post-market Clinical Study of the Fortilink-SC Ti
Run by BAAT Medical Products B.V. · NCT07834749 · Data updated 2026-11-12
This study tests the safety and performance of the Fortilink-SC Ti cage in adults undergoing standalone cervical interbody fusion for degenerative disc disease or cervical stenosis.
Quick facts
| Study type | Observational |
|---|---|
| Sex | All |
| Enrollment | 50 (estimated) |
| Sponsor | BAAT Medical Products B.V. Industry-sponsored |
| Locations | 2 sites (Madrid, Madrid and 1 other locations) |
| Status | Recruiting |
| Started | January 1, 2026 |
| Main results expected | December 31, 2027 |
| Study ends | December 31, 2027 |
| Registry record updated | September 22, 2026 |
| Trial ID | NCT07834749 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults with degenerative disc disease and/or cervical stenosis, eligible for standalone cervical interbody fusion at one or two levels between C2 and T1, who can provide informed consent.
✕Probably not a fit
Participants meeting criteria but who do not experience improved outcomes or who have complications may not receive additional benefits beyond standard care.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study collects data from routine care to monitor safety and performance of the Fortilink-SC Ti cage used in cervical interbody fusion. About 50 participants are enrolled across two Madrid hospitals and followed for up to one year. Data gathered include medical history, intraoperative details, and postoperative follow-up consistent with standard care. The study does not alter the treatment or follow-up procedures for participants. Fortilink-SC Ti cages have been on the market since 2020, and this study aims to actively gather real-world evidence in the intended patient population.
Why it matters
Potential benefit: If successful, the study could provide real-world data on the safety and performance of the Fortilink-SC Ti cage in cervical fusion.
How similar studies have gone: Previous real-world use of Fortilink-SC cages exists, and this study adds observational data to confirm safety in routine practice.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Willing and able to five voluntary informed consent 2. Skeletally mature patient 3. At least 6 weeks of nonoperative treatment 4. Degenerative disc disease (DDD) of the cervical spine at one or two contiguous levels between C2 and T1, with DDD being defined as neck pain of discogenic origin with degeneration of the disc confirmed by history and radiographic studies 5. Spinal stenosis Exclusion Criteria: 1. Active systematic infection or an active infection at the operative site 2. A demonstrated allergy or sensitivity to any of the implanted materials 3. Severe osteoporosis (confirmed by imaging in the patient's medical history or during screening) 4. Primary or metastatic tumours affecting the spine (confirmed by imaging in the patient's medical history or during screening) 5. Conditions that may place excessive stresses on the bones and the implants, including but not limited to morbid obesity or other degenerative diseases, , at the discretion of the investigator 6. Patients whose ability to follow postoperative restrictions, precautions and rehabilitation programs is limited 7. Fractures, severe deformities or a severe instability in the area of surgery (confirmed by imaging in the patient's medical history or during screening) 8. A medical or surgical situation that would preclude the benefit of surgery 9. Pregnancy 10. Patient's denial for operative treatment, post-operative rehabilitation program, follow up appointments and/or participation in the trial 11. Protocol specified surgical technique cannot be followed for the subject 12. Any other reason (in the judgment of the investigator).
Where it's running
-
Hospital Vithas de la Milagrosa
Madrid, Madrid, Spain Recruiting -
Hospital Universitario Vithas Madrid Aravaca
Moncloa-Aravaca, Madrid, Spain Recruiting
Study contacts
- Study coordinator: Tess Jimenez - van Dam, MSc
- Email: tess@baatmedical.com
- Phone: +31 - (0)6 - 267 18 663
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Real-world performance of the Synergy cervical disc
This observational program will collect real-world data to see how well and how safe the Synergy cervical disc is for adults with degenerative cervical disc disease who receive the implant.
-
Collecting real-world data on the Synergy cervical disc system
This study is collecting information on how well the Synergy cervical disc system works and its safety for patients with neck disc problems who have had or will have surgery.
-
Personalized pain management after lumbar spine surgery
This study is testing how genetic factors affect pain management after back surgery to see if it can help adults use opioids more safely and effectively.
-
Minimally invasive Ennovate® method for cervical pedicle screw placement
This project tests whether the minimally invasive Ennovate® method for placing cervical pedicle screws is safe and helps adults who need posterior cervical fusion.
-
High-resolution MRI of the cervical spine using 7 Tesla technology
This study is testing if a new type of high-resolution MRI can give better images of the neck for people with cervical back pain who need surgery.
-
Front-of-neck approaches for anterior cervical spine surgery and swallowing problems
This will see if the Smith-Robinson or strap-splitting front-of-neck approach causes fewer swallowing or voice problems for adults having anterior cervical spine surgery.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.